Literature DB >> 28834754

SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination.

Waaqo Daddacha1, Allyson E Koyen1, Amanda J Bastien1, PamelaSara E Head1, Vishal R Dhere1, Geraldine N Nabeta1, Erin C Connolly1, Erica Werner2, Matthew Z Madden1, Michele B Daly3, Elizabeth V Minten1, Donna R Whelan4, Ashley J Schlafstein1, Hui Zhang1, Roopesh Anand5, Christine Doronio1, Allison E Withers1, Caitlin Shepard3, Ranjini K Sundaram6, Xingming Deng1, William S Dynan2, Ya Wang1, Ranjit S Bindra6, Petr Cejka5, Eli Rothenberg4, Paul W Doetsch2, Baek Kim3, David S Yu7.   

Abstract

DNA double-strand break (DSB) repair by homologous recombination (HR) is initiated by CtIP/MRN-mediated DNA end resection to maintain genome integrity. SAMHD1 is a dNTP triphosphohydrolase, which restricts HIV-1 infection, and mutations are associated with Aicardi-Goutières syndrome and cancer. We show that SAMHD1 has a dNTPase-independent function in promoting DNA end resection to facilitate DSB repair by HR. SAMHD1 deficiency or Vpx-mediated degradation causes hypersensitivity to DSB-inducing agents, and SAMHD1 is recruited to DSBs. SAMHD1 complexes with CtIP via a conserved C-terminal domain and recruits CtIP to DSBs to facilitate end resection and HR. Significantly, a cancer-associated mutant with impaired CtIP interaction, but not dNTPase-inactive SAMHD1, fails to rescue the end resection impairment of SAMHD1 depletion. Our findings define a dNTPase-independent function for SAMHD1 in HR-mediated DSB repair by facilitating CtIP accrual to promote DNA end resection, providing insight into how SAMHD1 promotes genome integrity.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AGS; CLL; CtIP; DNA damage response; DNA end resection; DNA repair; HIV; autoimmune; dNTP; homologous recombination

Mesh:

Substances:

Year:  2017        PMID: 28834754      PMCID: PMC5576576          DOI: 10.1016/j.celrep.2017.08.008

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  72 in total

1.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

2.  The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.

Authors:  Elisa Franzolin; Giovanna Pontarin; Chiara Rampazzo; Cristina Miazzi; Paola Ferraro; Elisa Palumbo; Peter Reichard; Vera Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

Review 3.  The MRE11 complex: starting from the ends.

Authors:  Travis H Stracker; John H J Petrini
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02       Impact factor: 94.444

4.  SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.

Authors:  Constanze Schneider; Thomas Oellerich; Hanna-Mari Baldauf; Sarah-Marie Schwarz; Dominique Thomas; Robert Flick; Hanibal Bohnenberger; Lars Kaderali; Lena Stegmann; Anjali Cremer; Margarethe Martin; Julian Lohmeyer; Martin Michaelis; Veit Hornung; Christoph Schliemann; Wolfgang E Berdel; Wolfgang Hartmann; Eva Wardelmann; Federico Comoglio; Martin-Leo Hansmann; Alexander F Yakunin; Gerd Geisslinger; Philipp Ströbel; Nerea Ferreirós; Hubert Serve; Oliver T Keppler; Jindrich Cinatl
Journal:  Nat Med       Date:  2016-12-19       Impact factor: 53.440

5.  CtIP protein dimerization is critical for its recruitment to chromosomal DNA double-stranded breaks.

Authors:  Hailong Wang; Zhengping Shao; Linda Z Shi; Patty Yi-Hwa Hwang; Lan N Truong; Michael W Berns; David J Chen; Xiaohua Wu
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

Review 6.  Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy.

Authors:  Thomas Helleday; Helen E Bryant; Niklas Schultz
Journal:  Cell Cycle       Date:  2005-09-12       Impact factor: 4.534

7.  CtIP links DNA double-strand break sensing to resection.

Authors:  Zhongsheng You; Linda Z Shi; Quan Zhu; Peng Wu; You-Wei Zhang; Andrew Basilio; Nina Tonnu; Inder M Verma; Michael W Berns; Tony Hunter
Journal:  Mol Cell       Date:  2009-12-25       Impact factor: 17.970

8.  Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance.

Authors:  Matilda Rentoft; Kristoffer Lindell; Phong Tran; Anna Lena Chabes; Robert J Buckland; Danielle L Watt; Lisette Marjavaara; Anna Karin Nilsson; Beatrice Melin; Johan Trygg; Erik Johansson; Andrei Chabes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

9.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

10.  Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection.

Authors:  Junpeng Yan; Sarabpreet Kaur; Maria DeLucia; Caili Hao; Jennifer Mehrens; Chuanping Wang; Marcin Golczak; Krzysztof Palczewski; Angela M Gronenborn; Jinwoo Ahn; Jacek Skowronski
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

View more
  69 in total

Review 1.  Effects of β-HPV on DNA damage response pathways to drive carcinogenesis: a review.

Authors:  Danyal Tahseen; Peter L Rady; Stephen K Tyring
Journal:  Virus Genes       Date:  2021-01-03       Impact factor: 2.332

Review 2.  How cells ensure correct repair of DNA double-strand breaks.

Authors:  Joonyoung Her; Samuel F Bunting
Journal:  J Biol Chem       Date:  2018-02-05       Impact factor: 5.157

Review 3.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

4.  SAMHD1 inhibits epithelial cell transformation in vitro and affects leukemia development in xenograft mice.

Authors:  Karthik M Kodigepalli; Minghua Li; Serena Bonifati; Amanda R Panfil; Patrick L Green; Shan-Lu Liu; Li Wu
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

5.  SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation.

Authors:  Eddy Sanchai Thientosapol; Daniel Bosnjak; Timothy Durack; Igor Stevanovski; Michelle van Geldermalsen; Jeff Holst; Zeenat Jahan; Caitlin Shepard; Wolfgang Weninger; Baek Kim; Robert Brink; Christopher J Jolly
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-18       Impact factor: 11.205

6.  SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis.

Authors:  Karthik M Kodigepalli; Serena Bonifati; Nagaraja Tirumuru; Li Wu
Journal:  Cell Cycle       Date:  2018-07-17       Impact factor: 4.534

7.  TREX1 - Apex predator of cytosolic DNA metabolism.

Authors:  Sean R Simpson; Wayne O Hemphill; Teesha Hudson; Fred W Perrino
Journal:  DNA Repair (Amst)       Date:  2020-06-12

Review 8.  DNA Repair: Translation to the Clinic.

Authors:  E V Minten; D S Yu
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-03-12       Impact factor: 4.126

Review 9.  SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Authors:  Christopher H Mauney; Thomas Hollis
Journal:  Autoimmunity       Date:  2018-03-27       Impact factor: 2.815

10.  SAMHD1-mediated dNTP degradation is required for efficient DNA repair during antibody class switch recombination.

Authors:  Afzal Husain; Jianliang Xu; Hodaka Fujii; Mikiyo Nakata; Maki Kobayashi; Ji-Yang Wang; Jan Rehwinkel; Tasuku Honjo; Nasim A Begum
Journal:  EMBO J       Date:  2020-06-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.